Titan Bio-Tech Peer Comparison
BSE: 524717
₹372.60
As on 12-Nov-2026 14:32IST
Market cap
₹1,938 Cr
Revenue (TTM)
₹241 Cr
P/E Ratio
50.1
P/B Ratio
9.5
Div. Yield
0.1 %
| Titan Bio-Tech | Navin Fluorine | Tata Chemicals | BASF India | Alkyl Amines | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
1,938 | 50,449 | 15,432 | 12,727 | 8,208 |
Revenue (₹ Cr) |
241 | 4,066 | 15,420 | 16,963 | 1,760 |
Net Profit (₹ Cr) |
35.21 | 910.57 | -2,248.00 | 597.55 | 247.43 |
Net Margin (%) |
14.21 | 21.94 | -14.36 | 3.39 | 13.78 |
RoE (%) |
20.12 | 21.72 | -1.74 | 14.01 | 15.59 |
Price to Earnings |
50.11 | 55.40 | -- | 21.30 | 33.17 |
Price-To-Book |
9.46 | 11.31 | 0.70 | 2.96 | 5.00 |
Income Statement (₹ Cr)
| Titan Bio-Tech | Navin Fluorine | Tata Chemicals | BASF India | Alkyl Amines | |
|---|---|---|---|---|---|
|
Operating Revenue
|
240.97 | 4,065.90 | 15,420.00 | 16,999.21 | 1,759.87 |
|
Total Income
|
247.87 | 4,149.76 | 15,653.00 | 17,077.80 | 1,796.22 |
|
Total Expenditure
|
192.93 | 2,672.66 | 13,865.00 | 16,121.97 | 1,390.73 |
|
EBITDA
|
48.04 | 1,393.24 | 1,555.00 | 877.24 | 369.14 |
|
Depreciation
|
5.26 | 161.83 | 1,323.00 | 150.99 | 71.35 |
|
EBIT
|
42.78 | 1,231.41 | 232.00 | 726.25 | 297.79 |
|
Interest
|
0.97 | 118.04 | 598.00 | 14.81 | 1.36 |
|
Other Income
|
6.90 | 83.86 | 233.00 | 78.59 | 36.35 |
|
Exceptional Items
|
0.00 | -6.75 | -1,891.00 | 18.15 | 0.00 |
|
Profit before Tax
|
48.70 | 1,190.48 | -2,024.00 | 808.18 | 332.78 |
|
Provision for Tax
|
13.49 | 279.91 | 224.00 | 215.70 | 85.35 |
|
Profit after Tax
|
35.21 | 910.57 | -2,248.00 | 592.48 | 247.43 |
Liabilities (₹ Cr)
| Titan Bio-Tech | Navin Fluorine | Tata Chemicals | BASF India | Alkyl Amines | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
202.84 | 4,462.34 | 21,923.00 | 4,299.76 | 1,641.61 |
|
Minority Interest
|
0.00 | 0.00 | -189.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
6.86 | 1,342.40 | 9,894.00 | 213.83 | 177.86 |
|
Current Liabilities
|
35.83 | 1,025.85 | 6,473.00 | 4,584.51 | 214.93 |
|
Total Liabilities
|
222.51 | 6,846.40 | 38,998.00 | -- | 2,184.82 |
Assets (₹ Cr)
| Titan Bio-Tech | Navin Fluorine | Tata Chemicals | BASF India | Alkyl Amines | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
121.58 | 3,659.81 | 30,274.00 | 873.55 | 1,118.00 |
|
Current Assets
|
109.26 | 3,002.90 | 7,349.00 | 7,871.35 | 832.16 |
|
Total Assets
|
222.51 | 6,846.40 | 38,998.00 | -- | 2,184.82 |
|
Total Debt*
|
3.67 | 1,226.35 | 7,114.00 | -- | 0.00 |
|
Net Current Assets
|
73.43 | 1,977.05 | 876.00 | 3,286.84 | 617.23 |
|
Contingent Liabilities
|
0.93 | 8.87 | 1,099.00 | -- | 34.13 |
Cashflow (₹ Cr)
| Titan Bio-Tech | Navin Fluorine | Tata Chemicals | BASF India | Alkyl Amines | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
30.42 | 893.57 | 1,269.00 | -- | 238.55 |
|
Cash Flow from Investing Activities
|
-32.55 | -1,234.91 | -809.00 | -- | -137.10 |
|
Cash from Financing Activities
|
-1.53 | 344.21 | -670.00 | -- | -56.08 |
|
Net Cash Inflow / Outflow
|
-3.65 | 2.87 | -210.00 | -- | 45.37 |
Ratios
Profitability Ratios
| Titan Bio-Tech | Navin Fluorine | Tata Chemicals | BASF India | Alkyl Amines | |
|---|---|---|---|---|---|
|
ROCE (%)
|
22.94 | 21.39 | -3.09 | -- | 16.65 |
|
ROE (%)
|
20.12 | 21.72 | -1.74 | 14.00 | 15.59 |
|
ROA (%)
|
15.72 | 14.60 | -5.75 | 7.14 | 13.02 |
|
EBIT Margin (%)
|
17.75 | 30.29 | 1.50 | 4.27 | 16.92 |
|
Net Margin (%)
|
14.21 | 21.94 | -14.36 | 3.47 | 13.78 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Titan Bio-Tech | Navin Fluorine | Tata Chemicals | BASF India | Alkyl Amines | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
38.25 | 45.68 | 4.93 | 17.40 | 13.38 |
|
EBIT Growth (%)
|
85.26 | 91.71 | -71.32 | 61.18 | 39.38 |
|
Net Profit Growth (%)
|
71.01 | 105.03 | -1,081.66 | 48.01 | 35.83 |
|
EPS Growth (%)
|
-16.60 | 101.67 | -204.29 | 51.00 | 35.81 |
|
Book Value Growth (%)
|
18.35 | 52.04 | -1.80 | -- | 9.27 |
Valuation Ratios
| Titan Bio-Tech | Navin Fluorine | Tata Chemicals | BASF India | Alkyl Amines | |
|---|---|---|---|---|---|
|
Price / Earnings
|
21.68 | 54.05 | -41.33 | 22.10 | 33.37 |
|
Price / Book Value
|
9.29 | 11.11 | 0.71 | 2.98 | 5.03 |
|
Dividend Yield (%)
|
0.11 | 0.16 | 1.81 | 0.85 | 0.62 |
|
EV/EBITDA
|
39.68 | 35.52 | 13.79 | 13.60 | 21.68 |
|
Market Cap (₹ Cr)
|
1,891.16 | 31,554.29 | 14,869.85 | -- | 6,297.94 |
Solvency Ratios
| Titan Bio-Tech | Navin Fluorine | Tata Chemicals | BASF India | Alkyl Amines | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.20 | 0.20 | 0.00 | 0.01 |
|
Short term debt to equity ratio
|
0.02 | 0.05 | 0.07 | -- | -- |
|
Current Ratio
|
3.05 | 2.93 | 1.14 | 1.72 | 3.87 |
|
Quick Ratio
|
1.28 | 2.51 | 0.66 | 0.99 | 2.91 |
|
Interest Coverage
|
51.06 | 11.09 | -2.38 | 55.57 | 245.69 |
Operating Efficiency Ratios
| Titan Bio-Tech | Navin Fluorine | Tata Chemicals | BASF India | Alkyl Amines | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
11.27 | 21.87 | 16.26 | 20.58 | 17.52 |
|
Asset Turnover
|
1.08 | 0.65 | 0.39 | 2.05 | 0.93 |
|
Receivable days
|
36.86 | 73.48 | 46.38 | -- | 54.80 |
|
Inventory Days
|
94.34 | 42.29 | 65.59 | -- | 34.09 |
|
Payable days
|
30.76 | 116.22 | 250.14 | -- | 76.04 |
|
Cash Conversion Cycle
|
100.44 | -0.45 | -138.16 | -- | 12.85 |